Related Experiment Video
Updated: Dec 16, 2025

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
LRRK2 Phosphorylation, More Than an Epiphenomenon
Antoine Marchand1,2, Matthieu Drouyer1,2, Alessia Sarchione1,2
1University of Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.
Abstract:
Mutations in the Leucine Rich Repeat Kinase 2 (LRRK2) gene are linked to autosomal dominant Parkinson's disease (PD), and genetic variations at the LRRK2 locus are associated with an increased risk for sporadic PD. This gene encodes a kinase that is physiologically multiphosphorylated, including clusters of both heterologous phosphorylation and autophosphorylation sites. Several pieces of evidence indicate that LRRK2's phosphorylation is important for its pathological and physiological functioning. These include a reduced LRRK2 heterologous phosphorylation in PD brains or after pharmacological inhibition of LRRK2 kinase activity as well as the appearance of subcellular LRRK2 accumulations when this protein is dephosphorylated at heterologous phosphosites. Nevertheless, the regulatory mechanisms governing LRRK2 phosphorylation levels and the cellular consequences of changes in LRRK2 phosphorylation remain incompletely understood. In this review, we present current knowledge on LRRK2 phosphorylation, LRRK2 phosphoregulation, and how LRRK2 phosphorylation changes affect cellular processes that may ultimately be linked to PD mechanisms.
Insights
Leucine Rich Repeat Kinase 2 (LRRK2) gene mutations are linked to Parkinson's disease (PD). This review explores how LRRK2 phosphorylation impacts its function and cellular processes relevant to PD pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Mutations in the Leucine Rich Repeat Kinase 2 (LRRK2) gene are a known cause of autosomal dominant Parkinson's disease (PD).
- Genetic variations in the LRRK2 gene are also associated with an increased risk for developing sporadic PD.
- LRRK2 is a kinase that undergoes multiphosphorylation, crucial for its physiological and pathological functions.
Purpose of the Study:
- To review current knowledge on Leucine Rich Repeat Kinase 2 (LRRK2) phosphorylation.
- To discuss the regulatory mechanisms governing LRRK2 phosphorylation levels.
- To explore how alterations in LRRK2 phosphorylation affect cellular processes implicated in Parkinson's disease.
Main Methods:
- Literature review of existing research on LRRK2 phosphorylation.
- Analysis of evidence linking LRRK2 phosphorylation status to PD pathology.
- Synthesis of information on LRRK2 phosphoregulation and its cellular consequences.
Main Results:
- Reduced LRRK2 heterologous phosphorylation is observed in PD brains and upon pharmacological LRRK2 inhibition.
- Dephosphorylation of LRRK2 at heterologous phosphosites leads to its accumulation in subcellular compartments.
- The precise regulatory mechanisms and full cellular consequences of LRRK2 phosphorylation changes are not yet fully understood.
Conclusions:
- LRRK2 phosphorylation plays a critical role in both the normal function and the disease mechanisms of Parkinson's disease.
- Further research into LRRK2 phosphoregulation is necessary to fully elucidate its connection to PD.
- Understanding LRRK2 phosphorylation dynamics may reveal novel therapeutic targets for Parkinson's disease.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Receptor Tyrosine Kinases
Amplifying Signals via Enzymatic Cascade
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...

